Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News FDA rejects Correvio Pharma’s anti-arrhythmic drug Brinavess Correvio Pharma said that the US Food and Drug Administration (FDA) decided not to approve its anti-arrhythmic drug… bypharmanewsdailyDecember 25, 2019